The effect of levodopa on speech in advanced Parkinson’s Disease: acoustic analysis and correlation with motor features and dyskinesia
Objective: Analyse the effects of levodopa on speech and its possible relationship with motor features and dyskinesias in a group of advanced Parkinson’s disease (PD)…Objective assessment of motor states in Parkinson’s disease using partial least squares and smartphone data
Objective: In this study, we will investigate the behaviour of Partial Least Squares (PLS) regression for dimension reduction and prediction of motor states of Parkinson’s…Dopamine dysregulation syndrome and levodopa-induced dyskinesias in patients with Parkinson’s disease on the background of deep stimulation of the subthalamic nucleus
Objective: Assessment of the dynamics of the clinical manifestations of dofamine dysregulation syndrome (DDS) and the severity of dyskinesias in patients with Parkinson`s Disease (PD)…Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson’s disease.
Objective: To evaluate the efficacy of the 5-Hydroxytryptophan (5-HTP) on levodopa-induced motor complications in patients with Parkinson's disease (PD). Background: Several studies have indicated that…Wearable sensor use and monitoring effect of dopamine replacement therapy on motor parameters in a real life clinical setting
Objective: To explore the usefulness of wearable sensor data to inform treatment decisions in PD. Background: Wearable sensors are becoming increasingly incorporated into clinical care…Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS) based on Duration of Parkinson’s Disease and Dyskinesia
Objective: To assess differential item functioning (DIF) in the Unified Dyskinesia Rating Scale (UDysRS) to determine if the duration of Parkinson’s Disease (PD) and/or duration…Evaluation of Device-Assisted Treatment using a wearable accelerometry wrist sensor
Objective: To monitor the motor symptoms in patients with device-assisted therapy (DAT, defined as deep brain stimulation or infusion with apomorphine or levodopa) before and…Utilization patterns of Amantadine in Parkinson’s Disease patients enrolled in the French COPARK study
Objective: To explore amantadine IR utilization patterns in the French COPARK study. Background: Immediate release (IR) amantadine is marketed for the treatment of early and…STAT-ON: a Wearable Inertial System to Objectively Evaluate Motor Symptoms in Parkinson’s Disease
Objective: We present a wearable inertial system for the evaluation of motor symptoms in Parkinson's Disease. Background: PD is the second neurodegenerative disease affecting to around…Validation of the Hebrew version of the Unified Dyskinesia Rating Scale (UDysRS)
Objective: To assess the clinimetric properties of the Hebrew version of the UDysRS. Background: Dyskinesia is a common side effect of dopaminergic treatments for Parkinson's…
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 49
- Next Page »